Provided by Tiger Trade Technology Pte. Ltd.

Scinai Immunotherapeutics Ltd.

2.51
-0.1700-6.34%
Post-market: 2.50-0.0100-0.40%19:56 EDT
Volume:37.50K
Turnover:96.69K
Market Cap:1.30M
PE:-0.51
High:2.98
Open:2.70
Low:2.33
Close:2.68
52wk High:16.80
52wk Low:2.15
Shares:516.94K
Float Shares:436.23K
Volume Ratio:0.20
T/O Rate:8.60%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.8918
EPS(LYR):59.48
ROE:-26.53%
ROA:-36.15%
PB:0.21
PE(LYR):0.04

Loading ...

Scinai Swings to FY26 H1 Net Income of USD 1.57 Million; Operating Loss Widens to USD 4.61 Million

Reuters
·
Aug 24

Press Release: Scinai Reports First Half 2026 Corporate Highlights and Results with Spotlight on Growing CDMO Momentum

Dow Jones
·
Aug 24

NASDAQ Trade Halt Continues Reason not Available at 07:55 Am

Reuters
·
Aug 21

Press Release: Scinai Strengthens CDMO Leadership with Appointment of Eran Kuratz as Head of Supply Chain and Business Process Administration

Dow Jones
·
Aug 10

Scinai Q1 FY26 returns to profit at USD 3.58 million; revenue falls to USD 489,000

Reuters
·
Jun 10

Press Release: Scinai Reports First Quarter 2026 Financial Results and Provides Corporate Update Highlighting Expansion of CDMO Platform and Advancement of Strategic Growth Initiatives

Dow Jones
·
Jun 10

Scinai names Eilon Elmalem site head of Yavne CDMO facility

Reuters
·
May 20

Press Release: Scinai Biopharma Services Appoints Eilon Elmalem as Site Head of Yavne CDMO Facility

Dow Jones
·
May 20

ADRs Advance; Scinai Immunotherapeutics Ltd. Climbs 62%

Dow Jones
·
Apr 25

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:37 AM

Reuters
·
Apr 24

Why Is Scinai Immunotherapeutics Stock (SCNI) Up Today?

TIPRANKS
·
Apr 24

Scinai Immunotherapeutics announces $2.61M private placement

TIPRANKS
·
Apr 24

Press Release: Scinai Immunotherapeutics Announces $2.61 Million Private Placement Financing

Dow Jones
·
Apr 24

Scinai Immunotherapeutics completes strategic reorganization

TIPRANKS
·
Apr 06

Scinai Immunotherapeutics FY EPS $(3.56), Sales $1.311M Up From $658.000K YoY

Benzinga Earnings
·
Apr 01

Scinai Immunotherapeutics highlights expanded CDMO platform

TIPRANKS
·
Mar 19

Press Release: Scinai Signs Second Amendment to PinCell Option Agreement and Submits Revised EUR12 Million Non-Dilutive FENG Application to Advance PC111 Through Human Proof of Concept

Dow Jones
·
Mar 02